Is everything for sale?
Linking MP’s donations to anti-obesity drugs
The two old geezers have published several posts on the extravagant claims made on the properties of the latest crop of antiobesity drugs. As all our readers know, the more extreme the claim, the more interest we take in the evidence behind it.
Perhaps the most extraordinary claim is that made by Wes Streeting MP, the UK’s Secretary of State (SoS) for Health and Social Care, that the drug Zepbound, manufactured by Eli Lilly, may be part of the solution to lowering unemployment rates.
‘The long-term benefits of these drugs could be monumental in our approach to tackling obesity. For many people, these weight-loss jabs will be life-changing, help them get back to work, and ease the demands on our NHS,’ wrote Streeting.
Yes, it’s not a typo; you read it correctly.
Mr Streeting clarified, “Obesity-related health issues cost the UK’s National Health Service (NHS) 11 billion pounds ($14bn) each year, UK Health Secretary Streeting said while announcing the Eli Lilly study.
Mounjaro and Zepbo…
